Publicaciones en las que colabora con José Tuñón Fernández (8)

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2017

  1. 2016 ESC/EAS guidelines for the management of dyslipidemias

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 115.e-115.e

  2. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2016

  1. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    European Heart Journal, Vol. 37, Núm. 39, pp. 2999-3058l